FDA Drug recall D-0236-2017
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
- FDA Drug
- Class II
- terminated
- Published 2017-01-04
On 2017-01-04 the FDA classified a Class II recall of Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10 by Sandoz, citing failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0236-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-12-22 |
| Published | 2017-01-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sandoz |
| Distribution | MS, OH |
Product
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
Reason
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Identifiers
| code_info | Lot GG1539 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0236-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.